Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New series of cyclic pyrazine derivatives useful for diabetes

Aug. 7, 2000

Human adenovirus linked to obesity in animals

Aug. 7, 2000

Compounds with cholesterol biosynthesis-inhibitory activity claimed by Hanwha

Aug. 4, 2000

New integrin antagonists in development at Bayer

Aug. 4, 2000

Gene therapy boosts hemoglobin production in thalassemic mice

Aug. 4, 2000

Overexpression of UCP-3 results in reduced tissue mass in mice

Aug. 3, 2000

Magainin receives patent for novel obesity compound

Aug. 3, 2000

New findings on an old drug: metformin

Aug. 3, 2000

Akzo Nobel presents new agents for controlling fertility

Aug. 2, 2000

Pharmacia introduces first vaginal estrogen tablet in U.S.

Aug. 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...